What You Should Know:
- PathAI, a provider of AI-powered pathology solutions, today announced the launch of PathAssist Derm, an innovative tool designed to streamline the analysis of skin lesions.
- Available now on the AISight® Image Management System (IMS), this research tool automates specimen orientation and identification, enabling pathologists to review samples more efficiently and accurately.
PathAssist Derm Capabilities
PathAssist Derm is the latest addition to
Read More
Digital Pathology
Mayo Clinic Launches Digital Pathology Platform
What You Should Know:
- Mayo Clinic launches Mayo Clinic Digital Pathology, a platform designed to leverage the power of its vast digital slide archive to transform pathology and accelerate medical advancements.
- The initiative, powered by a collaboration with NVIDIA and Aignostics, aims to unlock the potential of digital pathology and drive innovation in diagnostics and treatment.
Addressing the Challenges of Analog Pathology
Traditional pathology practices often rely on
Read More
Deciphex Secures $32.3M for AI-Powered Digital Pathology
What You Should Know:
- Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising $32.3 million to address the acute global pathology crisis. Led by Molten Ventures with significant participation from ACT Venture Capital, Seroba, Charles River Laboratories (NYSE: CRL), IRRUS Investments, HBAN Medtech Syndicate and Nextsteps Capital, the funding will advance Deciphex's mission to democratize access to high-quality
Read More
The Role of AI-Enabled Pathology in Enhancing Patient Care
There’s no doubt that cancer screening, early detection, and swift intervention are invaluable for improving patients’ health outcomes. In this process, once a clinician has determined a need for a tissue biopsy after detecting an abnormality, diagnostic accuracy and efficiency become crucial factors in the treatment journey.
We’ve seen great advancements when it comes to screening and targeted therapies. However, these treatments cannot occur without an accurate and timely diagnosis.
Read More
Owkin, Proscia Partner to Streamline MSI Testing for Colorectal Cancer
What You Should Know:
- Owkin, an AI-biotech company specializing in precision medicine, and Proscia, a leader in AI-enabled pathology solutions, have announced a strategic partnership to improve MSI testing for colorectal cancer (CRC). This collaboration aims to enhance the efficiency and accessibility of MSI screening, ultimately leading to better patient outcomes.
- Beyond MSI testing, Owkin and Proscia plan to collaborate on developing and commercializing additional AI solutions
Read More
Q/A: Proscia Co-Founder Talks Impact of DICOM in Digital Pathology
The world of digital pathology is undergoing a significant transformation, with the adoption of DICOM (Digital Imaging and Communications in Medicine) emerging as a game-changer. This international standard, already widely used in radiology, is poised to transform how pathology images and data are stored, shared, and analyzed.
By promoting interoperability among various hardware and software solutions, DICOM empowers laboratories to build more efficient and scalable digital pathology
Read More
Aignostics Secures $34M to Advance AI-Powered Pathology and Precision Medicine
What You Should Know:
- Aignostics, a leading AI company specializing in pathology data analysis, raised $34M in Series B funding, led by ATHOS with participation from Mayo Clinic and growth financing from HTGF, alongisde existing investors Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund, and VC Fonds Technologie managed by IBB Ventures.
- Aignostics combines proprietary access to multimodal clinical data with cutting-edge AI technology and rigorous
Read More
Bioptimus and Proscia Accelerate AI Development in Pathology with H-optimus-0 Integration
What You Should Know:
- Bioptimus, a French startup developing cutting-edge AI foundation models for biology, has announced a strategic partnership with Proscia, a provider of AI-enabled pathology solutions.
- The collaboration integrates Bioptimus' H-optimus-0 foundation model into Proscia's Concentriq® Embeddings, empowering researchers and data scientists to achieve breakthroughs in AI development at an unprecedented pace.
Unlocking the Power of Foundation
Read More
Accelerating Drug Discovery: Proscia Launches Concentriq Embeddings and AI Toolkit
What You Should Know:
- Proscia, a provider of AI-powered pathology solutions, is accelerating the pace of drug discovery and diagnostic development with the launch of Concentriq® Embeddings and the Proscia AI Toolkit.
- These powerful new tools empower life sciences organizations to leverage the full potential of artificial intelligence in pathology, leading to faster breakthroughs and improved patient outcomes.
Transforming AI Development in Pathology
Integrated into
Read More
PathPresenter Raises $7.5M to Accelerate Digital Pathology Workflows
What You Should Know:
- PathPresenter, the global image sharing platform for pathology, announced today that it has closed a Series A funding round of $7.5 million to accelerate the adoption of the company’s enterprise pathology workflow solution.
- The funding was led by AVANT BIO, with participation from Barco NV and Modi Ventures. The funds will be used to advance the features and interoperability of the vendor-agnostic platform, invest in talent across engineering and commercial
Read More
